Tenet Healthcare Corp. (THC) Misses Q4 EPS by 4c; Raises FY12 EBITDA Outlook
Get Alerts THC Hot Sheet
Price: $270.13 +0.37%
EPS Growth %: +26.2%
Financial Fact:
Income tax benefit (expense): -1M
Today's EPS Names:
SICP, MNSB, CFFI, More
EPS Growth %: +26.2%
Financial Fact:
Income tax benefit (expense): -1M
Today's EPS Names:
SICP, MNSB, CFFI, More
Join SI Premium – FREE
Tenet Healthcare Corp. (NYSE: THC) reported Q4 EPS of $0.10, $0.04 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $2.23 billion versus the consensus estimate of $2.4 billion.
Raised its FY12 adj-EBITDA guidance from $1.2-$1.3 billion to $1.225-$1.35 billion.
For earnings history and earnings-related data on Tenet Healthcare Corp. (THC) click here.
Raised its FY12 adj-EBITDA guidance from $1.2-$1.3 billion to $1.225-$1.35 billion.
For earnings history and earnings-related data on Tenet Healthcare Corp. (THC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deckers Brands (DECK) Tops Q2 EPS by 24c; raises guidance
- Scotiabank Names Top Utility Stocks Amid Data Center Growth
- Procter & Gamble (PG) Tops Q1 EPS by 11c, updates guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share